| 3LNK: reference: Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization., Cumming J, Babu S, Huang Y, Carrol C, Chen X, Favreau L, Greenlee W, Guo T, Kennedy M, Kuvelkar R, Le T, Li G, McHugh N, Orth P, Ozgur L, Parker E, Saionz K, Stamford A, Strickland C, Tadesse D, Voigt J, Zhang L, Zhang Q, Bioorg Med Chem Lett. 2010 Mar 12. PMID: 20347593 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).